Principal Financial Group Inc. Has $90.20 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Principal Financial Group Inc. grew its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 4.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,434,476 shares of the pharmacy operator's stock after buying an additional 66,244 shares during the period. Principal Financial Group Inc. owned 0.11% of CVS Health worth $90,200,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Pzena Investment Management LLC raised its holdings in CVS Health by 132.9% during the second quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator's stock worth $764,023,000 after purchasing an additional 7,382,931 shares in the last quarter. Hotchkis & Wiley Capital Management LLC increased its position in shares of CVS Health by 34.8% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock valued at $748,085,000 after purchasing an additional 3,071,613 shares during the period. State Street Corp raised its stake in shares of CVS Health by 3.6% in the 3rd quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock worth $3,554,475,000 after buying an additional 1,989,066 shares in the last quarter. TOMS Capital Investment Management LP bought a new position in CVS Health during the third quarter valued at about $121,987,000. Finally, Pathway Financial Advisers LLC grew its holdings in CVS Health by 5,864.2% during the third quarter. Pathway Financial Advisers LLC now owns 1,730,343 shares of the pharmacy operator's stock worth $108,804,000 after acquiring an additional 1,701,331 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. TD Cowen upped their price target on shares of CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a report on Monday, November 25th. Royal Bank of Canada cut their target price on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a research note on Friday, November 15th. Barclays decreased their price target on shares of CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a research report on Thursday, November 7th. Wells Fargo & Company upgraded CVS Health from an "equal weight" rating to an "overweight" rating and increased their price objective for the company from $60.00 to $66.00 in a research report on Monday, November 18th. Finally, UBS Group lifted their target price on CVS Health from $60.00 to $62.00 and gave the stock a "neutral" rating in a report on Thursday, November 7th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have given a buy rating to the company's stock. According to data from MarketBeat.com, CVS Health presently has an average rating of "Moderate Buy" and a consensus target price of $70.50.

CVS Health Stock Performance

Shares of CVS stock traded up $0.58 during trading on Friday, reaching $44.36. The company had a trading volume of 21,082,219 shares, compared to its average volume of 11,653,444. CVS Health Co. has a one year low of $43.60 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The firm's 50 day simple moving average is $56.24 and its two-hundred day simple moving average is $58.23. The company has a market capitalization of $55.82 billion, a PE ratio of 11.26, a PEG ratio of 0.89 and a beta of 0.54.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health's revenue was up 6.3% compared to the same quarter last year. During the same period last year, the business posted $2.21 EPS. Sell-side analysts forecast that CVS Health Co. will post 5.32 earnings per share for the current year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.